MindMed Appoints Dr. Robert Dworkin to Scientific Advisory Board Post published:August 10, 2021 Post category:Press Release
MindMed Joins Digital Medicine Society to Improve Health Outcomes and Equity Using Technology Post published:August 3, 2021 Post category:Press Release
MindMed Announces Initiation of Phase 1 Clinical Trial of Intravenous DMT Post published:July 28, 2021 Post category:Press Release
MindMed Announces Partnership with Datavant, a Leading Health Data Connectivity Company Post published:July 8, 2021 Post category:Press Release
MindMed Included in FTSE Russell 3000® Index Post published:June 28, 2021 Post category:Press Release
MindMed Appoints MGH Psychiatrist-in-Chief Dr. Maurizio Fava to Scientific Advisory Board Post published:June 23, 2021 Post category:Press Release
MindMed Appoints Pharmaceutical Veteran Peter Bergethon, M.D. to Scientific Advisory Board Post published:June 17, 2021 Post category:Press Release
MindMed Announces Chief Executive Officer Transition Post published:June 9, 2021 Post category:Press Release
MindMed announces shareholder Meeting Results Post published:May 27, 2021 Post category:Press Release
MindMed and Liechti Lab in Basel Switzerland Publish First Pharmacogenetic Data on LSD to Help Guide Personalized Dosing Post published:May 26, 2021 Post category:Press Release